Lifileucel ni iki: Ibikoreshwa, Urutonde rw'imiti, Ingaruka zayo n'ibindi

Lifileucel ni uburyo bushya bwo kuvura kanseri bukoresha uturemangingo twawe twikingira kugira ngo turwanye melanoma. Ubu buryo bushya bufata uturemangingo twikingira mu gishyitsi cyawe, tukongerwa mu laboratori, hanyuma tukongera gusubizwa mu mubiri wawe kugira ngo dufashe kurimbura uturemangingo twa kanseri neza.

Bitekereze nk'uko uha umubiri wawe wikingira imbaraga nyinshi n'ingabo zizi neza uko zimenya kanseri yawe yihariye. Ubu buryo bwihariye bugize iterambere rikomeye mu kwita ku barwayi ba kanseri, butanga icyizere gishya ku bantu bafite melanoma yateye imbere.

Lifileucel ni iki?

Lifileucel ni ubwoko bwa immunotherapy yitwa tumor-infiltrating lymphocyte (TIL) therapy. Ikorerwa byihariye mu turemangingo twawe twikingira twamaze kurwanya kanseri yawe.

Ubu buryo butangira igihe abaganga bakuraho igice cy'igishyitsi cyawe. Abahanga noneho batandukanya uturemangingo twikingira twageragezaga kurwanya kanseri yawe bakongera miliyoni nyinshi muri laboratori yihariye mu byumweru byinshi.

Utu turemangingo twikingira twongerewe noneho dusubizwa muri wowe binyuze mu gutera urushinge rwa IV. Kubera ko bava mu mubiri wawe kandi bamaze kugaragaza ko bashobora kumenya kanseri yawe, akenshi bikora neza kurusha uko umubiri wawe wikingira wenyine wakora.

Lifileucel ikoreshwa mu kuvura iki?

Lifileucel yemerejwe byihariye kuvura melanoma yateye imbere yateye mu bindi bice by'umubiri wawe. Igenewe abantu kanseri yabo yakomeje gukura nubwo bakoresheje izindi miti.

Muganga wawe ashobora kugusaba ubu buryo niba waramaze gukoresha imiti ya immunotherapy nka checkpoint inhibitors cyangwa imiti igamije, kandi kanseri yawe ntiyitabe cyangwa yatangiye kongera gukura. Ubu buvuzi butanga uburyo bushya igihe izindi nzira zitagize icyo zikora.

Ubu buvuzi bufite agaciro gakomeye cyane kuko kanseri ya melanoma ishobora kuba ikaze kandi bigatinda kuyivura iyo imaze gukwira. Lifileucel itanga uburyo bwihariye bukoresha uburyo umubiri wawe wikingira.

Lifileucel ikora ite?

Lifileucel ikora yongera cyane umubare w'uturemangingo tw'umubiri turwanya kanseri. Utu turemangingo, twitwa T-cells, ni nk'abasirikare b'inzobere bashobora kumenya no kurimbura uturemangingo twa kanseri.

Uburyo bwo kuvura bugizwe n'intambwe nyinshi zikorera hamwe. Mbere na mbere, uturemangingo tw'umubiri turwanya kanseri dukurwa mu gishyitsi cyawe maze tukongerwa hanze y'umubiri wawe. Mbere yo kubisubiza, uzahabwa imiti ya chemotherapy kugira ngo igabanye by'agateganyo uturemangingo twawe tw'umubiri turwanya kanseri, bitume dushya dukora neza.

Iyo uturemangingo twongerewe imbaraga twasubijwe mu maraso yawe, bigenda mu mubiri wawe wose bishakisha uturemangingo twa kanseri two kurwanya. Kubera ko byaturutse mu gishyitsi cyawe, biramaze kumenya uko kanseri yawe isa kandi irashobora kuyirwanya neza kurusha uko umubiri wose wikingira.

Nkwiriye gufata Lifileucel nte?

Lifileucel itangwa nk'urukingo rumwe rwo mu maraso mu bitaro. Ntushobora gufata uyu muti uri mu rugo, kuko bisaba kugenzurwa na muganga witonze mu gihe cyose cyo kuvurwa.

Mbere yo guhabwa urukingo, uzakenera kurangiza gahunda yo kwitegura ya chemotherapy. Ibi mubisanzwe bikubiyemo gufata imiti nka cyclophosphamide na fludarabine mu gihe cy'icyumweru kugira ngo utegure umubiri wawe wikingira.

Urukingo nyirizina rusanzwe rufata iminota 15 kugeza kuri 30, ariko uzakenera kuguma mu bitaro kugira ngo ukurikiranwe. Nyuma yo guhabwa urukingo, uzakira kandi imiti ifasha nka interleukin-2 kugira ngo ifashe uturemangingo tw'umubiri turwanya kanseri gukura no gukora neza mu mubiri wawe.

Nkwiriye gufata Lifileucel igihe kingana iki?

Lifileucel akenshi itangwa nk'urugero rumwe rw'imiti, ntabwo ari umuti ukomeza guhabwa. Uzasabwa guterwa urushinge rumwe rw'uturemangingo tw'umubiri twateguwe by'umwihariko, hamwe na chemotherapy itegura umubiri n'imiti ifasha.

Uburyo bwose bwo kuvurwa, kuva mu gukuraho ibibyimba kugeza ku gukira, mubisanzwe bifata ibyumweru bigera kuri 6 kugeza kuri 8. Ibi birimo igihe gikenewe kugirango uturemangingo tw'umubiri wawe dukure muri laboratori ndetse n'igihe cyo gukira kwawe mu bitaro.

Itsinda ryawe ry'abaganga rizagukurikiranira hafi mu byumweru byinshi nyuma yo kuvurwa kugirango barebe ibisubizo byiza ndetse n'ingaruka zose zishobora kubaho. Ubuvuzi bukurikira no gukurikiranwa bizakomeza mu mezi menshi kugirango hamenyekane uko imiti ikora neza.

Ni izihe ngaruka ziterwa na Lifileucel?

Kimwe n'ubundi buvuzi bwa kanseri, lifileucel ishobora gutera ingaruka, nubwo abantu benshi basanga zicungwa neza n'ubufasha bw'ubuvuzi bukwiye. Ingaruka nyinshi zifitanye isano na chemotherapy itegura umubiri no gukora kw'umubiri w'umuntu.

Kumenya icyo witegura bishobora kugufasha kwitegura mu mutwe no mu mubiri urugendo rwo kuvurwa. Hano hari ingaruka ushobora guhura nazo, dutangiriye ku zikunze kubaho:

• Kugira umunaniro n'intege nke bishobora kumara ibyumweru byinshi
• Isesemi no kugabanya ubushake bwo kurya
• Urubura n'ubukonje mugihe umubiri wawe ukora
• Umubare muto w'uturemangingo tw'amaraso, bigatuma wibasirwa n'indwara
• Uruhu rwakomeretse cyangwa ibiheri
• Impiswi cyangwa ibibazo byo mu gifu

Abantu bamwe bashobora guhura n'ingaruka zikomeye ariko zitabaho cyane zisaba ubufasha bw'ubuvuzi bwihutirwa:

• Indwara zikomeye ziterwa no kudakora neza kw'umubiri w'umuntu
• Ibibazo by'umutima cyangwa impinduka z'umuvuduko w'amaraso
• Impinduka z'imikorere y'impyiko cyangwa umwijima
• Kugorana guhumeka cyangwa kubyimba kw'ibihaha
• Ubwivumbagatanyo bukomeye bw'umubiri mugihe cyo guterwa urushinge

Abaganga bazakwitaho cyane

Itsinda ry'abaganga bazakwitaho cyane mu gihe cyose cy'ubuvuzi kandi bazaguha imiti ifasha kugabanya izo ngaruka. Ingaruka nyinshi ziba igihe gito kandi zigenda zikemura uko umubiri wawe wimenyereza ubuvuzi.

Ninde utagomba gufata Lifileucel?

Lifileucel ntibereye buri wese, kandi muganga wawe azasuzuma neza niba ubu buvuzi bukwiye kuri wowe. Indwara zimwe na zimwe cyangwa ibihe bishobora gutuma ubu buvuzi bugira akaga.

Itsinda ry'abaganga bazatekereza ibintu byinshi mbere yo kugusaba ubu buvuzi. Ibi bintu bifasha kureba umutekano wawe n'umusaruro mwiza ushoboka:

• Udukoko dukomeye dukora cyangwa indwara z'umubiri zirwanya indwara
• Indwara zikomeye z'umutima, impyiko, cyangwa umwijima
• Abantu baherutse kwimura ibice by'umubiri
• Gusama cyangwa konsa
• Indwara zimwe na zimwe ziterwa n'umubiri zishobora kwiyongera
• Kutabasha gukora imiti ya chemotherapy isabwa

Byongeye kandi, abantu bamwe bashobora kutaba abakandida beza kubera ibisabwa byihariye by'uburyo bwo kuvura:

• Uduce tw'umubiri tw'indwara tudahagije kugirango dukuremo uturemangingo tw'umubiri turwanya indwara
• Ubuzima muri rusange butameze neza kugirango twihanganire ubuvuzi bukomeye
• Kanseri yageze mu bwonko mu buryo bumwe
• Uruhare rwa vuba mu bindi bigeragezo by'ubuvuzi

Muganga wawe azaganira neza ibijyanye n'uko ubuzima bwawe bumeze kandi agufashe gusobanukirwa niba lifileucel ari uburyo bwiza kuri wowe. Bazanasuzuma ubundi buvuzi niba ubu buvuzi butakwiriye.

Izina ry'ubwoko bwa Lifileucel

Lifileucel icururizwa ku izina ry'ubwoko rya Amtagvi. Iri ni ryo zina ry'ubucuruzi uzabona ku nyandiko z'ubuvuzi n'impapuro z'ubwishingizi.

Uyu muti watejwe imbere na Iovance Biotherapeutics kandi wemerejwe na FDA mu 2024. Mu gihe muganira ku buryo bwo kuvura n'itsinda ry'abaganga cyangwa sosiyete y'ubwishingizi, bashobora kuwuvuga ku izina iryo ari ryo ryose.

Kubera ko iyi ari imiti yihariye, iboneka gusa mu bigo byemewe bivura kanseri bifite ibikoresho bikwiye n'abakozi babihuguriwe gukoresha ubu bwoko bwo kuvura indwara zifashishije imikorere y'umubiri.

Uburyo bwo kuvura bwasimbura Lifileucel

Niba lifileucel itakwemerera, hari ubundi buryo bwo kuvura bushobora kuboneka bwo kuvura melanoma yateye imbere. Muganga wawe w'inzobere mu kuvura kanseri azagufasha gushakisha izo nzira zindi zishingiye ku miterere yawe yihariye.

Uburyo bundi bwo kuvura bwo gufashisha imikorere y'umubiri bushobora kuba bukwiye kuri gahunda yawe yo kuvurwa. Ubu buryo bwo kuvura butandukanye ariko bushobora no gufasha umubiri wawe kurwanya kanseri:

• Abakumira ibimenyetso by'indwara nka pembrolizumab (Keytruda) cyangwa nivolumab (Opdivo)
• Ubuvuzi buvura kanseri bufatanyije
• Ubuvuzi bwa CAR-T cell (kubwoko runaka bwa kanseri)
• Igeragezwa ryo gukoresha uburyo bushya bwo kuvura kanseri hifashishijwe imikorere y'umubiri

Ubuvuzi gakondo bwa kanseri bushobora no kuba uburyo bwo kuvura, bitewe n'imiterere ya kanseri yawe:

• Imiti igamije kuvura ihinduka ry'imiterere ya genetike
• Imiti ivura kanseri ihuriweho yagenewe melanoma
• Ubuvuzi bwo gukoresha imirasire ku duce twihariye tw'umubiri turwaye
• Kubaga kugirango bakuremo ibice bya kanseri byihariye

Itsinda ryawe ry'abaganga bazatekereza ku bintu nk'ubuzima bwawe muri rusange, ubuvuzi wabanje guhabwa, n'imiterere yihariye ya kanseri yawe mugihe bagusaba uburyo bwo kuvura busimbura. Uburyo bwose bufite inyungu zabwo n'ingaruka zishobora guterwa.

Ese Lifileucel iruta ubundi buryo bwo kuvura melanoma?

Lifileucel itanga inyungu zidasanzwe, ariko niba "iruta" biterwa n'imimerere yawe bwite n'uburyo wabyitwayemo ku bundi buvuzi. Ntabwo ari ngombwa ko ari uburyo bwo kuvura bwa mbere ahubwo ni uburyo bw'agaciro iyo izindi nzira zitagize icyo zikora.

Inyungu nyamukuru ya lifileucel ni uburyo bwayo bwihariye. Bitandukanye n'ubundi buvuzi bukora muri rusange kurwanya kanseri, ubu buvuzi bukoresha uturemangingo twawe tw'umubiri twamaze kugaragaza ko bashobora kumenya igituntu cyawe cyihariye.

Ubushakashatsi bwakozwe ku barwayi bwagaragaje ibisubizo byiza ku bantu batari barabonye ibisubizo ku zindi nkingo zikoreshwa mu kuvura kanseri. Ariko, bisaba uburyo bwo kuvura burushijeho gukomera ugereranije n'imiti inyobwa cyangwa inshinge zoroheje ziterwa mu urugingo rw'umubiri.

Umuvuzi wawe w'indwara ya kanseri azagufasha gupima inyungu zishoboka n'ibibazo byo kuvurwa. Guhitamo neza biterwa n'ibintu nk'ubuzima bwawe muri rusange, imiti wabanje gufata, n'ibyo ukunda ku bijyanye n'uburyo bwo kuvurwa.

Ibibazo bikunze kubazwa kuri Lifileucel

Ese Lifileucel irakwiriye ku bantu barwaye indwara z'umutima?

Abantu barwaye indwara z'umutima bakeneye isuzuma ryitondewe mbere yo guhabwa lifileucel. Imiti ikoreshwa mbere yo gutera urukingo rwo mu maraso no gukangura imikorere y'umubiri birashobora gushyira umuvuduko ku mikorere y'umutima wawe.

Umuvuzi w'indwara z'umutima n'umuvuzi wawe w'indwara ya kanseri bazakorana kugira ngo basuzume ubuzima bw'umutima wawe. Bashobora kugusaba gukurikiranwa umutima wawe mu gihe uvurwa cyangwa guhindura gahunda yo kuvura kugira ngo bagabanye ibibazo byo ku mutima. Abantu bamwe bafite indwara z'umutima zigenzurwa neza barashobora kwakirwa ubu buvuzi mu buryo butabangamiye ubuzima bwabo.

Nkwiriye gukora iki niba ngize ingaruka zikomeye?

Vugana n'ikipe yawe y'ubuvuzi ako kanya niba ugize ingaruka zikomeye nk'umuriro mwinshi, guhumeka bigoye, kuribwa mu gituza, cyangwa ibimenyetso by'ubwandu bukomeye. Ntuzategereze ngo urebe niba ibimenyetso bigenda byikora.

Kubera ko uzaba ukurikiranywa hafi mu bitaro mu gihe uvurwa no nyuma yaho, abakozi b'ubuvuzi bazaba bareba ibi bibazo. Bafite uburyo bwo gukemura ingaruka zikomeye vuba kandi neza.

Bifata igihe kingana iki kugira ngo ubone ibisubizo bya Lifileucel?

Igisubizo cya mbere kuri lifileucel rimwe na rimwe gishobora kugaragara mu byumweru, ariko bishobora gufata amezi menshi kugira ngo usuzume neza imikorere y'ubuvuzi. Muganga wawe azakoresha ibizamini n'ibindi biganiro kugira ngo akurikirane uko kanseri yawe yitwara.

Abantu bamwe babona impinduka zihuse, mu gihe abandi bashobora gutinda kubona ibisubizo. Itsinda ryawe ryita ku buzima rizagena gahunda yo kugusuzuma buri gihe kugira ngo bakurikirane iterambere ryawe kandi bahindure gahunda yawe yo kwitabwaho uko bikwiye.

Ni ryari nshobora gusubukura ibikorwa bisanzwe nyuma ya Lifileucel?

Igihe cyo gukira kiratandukanye, ariko abantu benshi bakeneye ibyumweru byinshi kugeza ku mezi mbere yo gusubira mu bikorwa bisanzwe. Sisitemu yawe y'ubudahangarwa ikeneye igihe cyo koroherwa na chimiothérapie yo kwitegura no kumenyera selile nshya z'ubudahangarwa.

Itsinda ryawe ry'abaganga rizatanga amabwiriza yihariye ashingiye ku iterambere ryawe ryo gukira. Bazakumenyesha igihe bizaba byemewe gusubira ku kazi, gukora imyitozo ngororamubiri, n'ibindi bikorwa bisanzwe. Umenye umubiri wawe kandi ntukihutishe inzira yo gukira.

Ese ubwishingizi buzishyura imiti ya Lifileucel?

Gahunda nyinshi z'ubwishingizi zishyura lifileucel iyo ari ngombwa mu buvuzi bwa melanoma yateye imbere, ariko ubwishingizi burashobora gutandukana cyane. Ubuvuzi buhenze, bityo imbere yo kubyemera birakenewe.

Abajyanama b'imari b'itsinda ryawe ryita ku buzima bashobora kugufasha gusobanukirwa inyungu z'ubwishingizi bwawe no gushakisha gahunda z'imfashanyo niba bikwiye. Bazakorana n'ikigo cyawe cy'ubwishingizi kugira ngo babone uburenganzira bukenewe mbere yo gutangira kuvurwa.